Literature DB >> 14559832

Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death.

Betsy J Barnes1, Merrill J Kellum, Karen E Pinder, J Augusto Frisancho, Paula M Pitha.   

Abstract

We have previously shown a critical role for IFN regulatory factor 5 (IRF-5) in the innate immune response to virus infection. For the first time, we now show that although IRF-5 is a direct target of p53, its cell cycle regulatory and proapoptotic effects are p53 independent. IRF-5 inhibits both in vitro and in vivo B-cell lymphoma tumor growth in the absence of wild-type p53. The molecular mechanism(s) of IRF-5-mediated growth inhibition is associated with a G(2)-M cell cycle arrest and modulation of growth regulatory and proapoptotic genes, including p21, Bak, DAP kinase 2, and Bax. Taken together, these data indicate that although IRF-5 is a downstream target of p53, its growth inhibitory and proapoptotic effects are independent of p53.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559832

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  68 in total

1.  Retinoic acid exerts dual regulatory actions on the expression and nuclear localization of interferon regulatory factor-1.

Authors:  Xin M Luo; A Catharine Ross
Journal:  Exp Biol Med (Maywood)       Date:  2006-05

2.  Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.

Authors:  Di Feng; Rivka C Stone; Maija-Leena Eloranta; Niquiche Sangster-Guity; Gunnel Nordmark; Snaevar Sigurdsson; Chuan Wang; Gunnar Alm; Ann-Christine Syvänen; Lars Rönnblom; Betsy J Barnes
Journal:  Arthritis Rheum       Date:  2010-02

3.  Critical role of IRF-5 in regulation of B-cell differentiation.

Authors:  Chunyang Lien; Chee-Mun Fang; David Huso; Ferenc Livak; Runqing Lu; Paula M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-22       Impact factor: 11.205

Review 4.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

5.  Dual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytes.

Authors:  Yong Zhao; Dongsheng Xu; Yanjun Jiang; Luwen Zhang
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

6.  Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication.

Authors:  Elizabeth Turpin; Kimberly Luke; Jeremy Jones; Terrence Tumpey; Kouacou Konan; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Identification of new SLE-associated genes with a two-step Bayesian study design.

Authors:  D L Armstrong; A Reiff; B L Myones; F P Quismorio; M Klein-Gitelman; D McCurdy; L Wagner-Weiner; E Silverman; J O Ojwang; K M Kaufman; J A Kelly; J T Merrill; J B Harley; S-C Bae; T J Vyse; G S Gilkeson; P M Gaffney; K L Moser; C Putterman; J C Edberg; E E Brown; J Ziegler; C D Langefeld; R Zidovetzki; C O Jacob
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

Review 8.  Genetic associations in type I interferon related pathways with autoimmunity.

Authors:  Angélica M Delgado-Vega; Marta E Alarcón-Riquelme; Sergey V Kozyrev
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

9.  Functional analysis of a dominant negative mutation of interferon regulatory factor 5.

Authors:  Long Yang; Tiejun Zhao; Xiaoliu Shi; Peyman Nakhaei; Yunling Wang; Qiang Sun; John Hiscott; Rongtuan Lin
Journal:  PLoS One       Date:  2009-05-11       Impact factor: 3.240

10.  Lack of association of two polymorphisms of IRF5 with Behcet's disease.

Authors:  Haijun Li; Peizeng Yang; Zhengxuan Jiang; Shengping Hou; Lin Xie
Journal:  Mol Vis       Date:  2009-10-07       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.